Gemtuzumab ozogamicin - Pfizer
At a glance
- Drug Originator UCB
- Drug Licenced by Pfizer
- Drug Class Aminoglycosides; Antineoplastics; Cytostatic antibiotics; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action DNA damage stimulants
- USA Patent Applicants WYETH PHARMS INC
- USA Patents 162
- BLAs 1
- International Patents 1,922

Disclaimer